427 related articles for article (PubMed ID: 29337962)
21. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
Taal BG; Van Tinteren H; Zoetmulder FA;
Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
[TBL] [Abstract][Full Text] [Related]
22. Analysis of clinicopathological features and prognosis of 1315 cases in colorectal cancer located at different anatomical subsites.
Feng Z; Shi X; Zhang Q; Zhang X; Li X; Chen Z; Liu D; Sun B; Zuo Y; Ren S
Pathol Res Pract; 2019 Oct; 215(10):152560. PubMed ID: 31375274
[TBL] [Abstract][Full Text] [Related]
23. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Implications of Extranodal Extension in Relation to Colorectal Cancer Location.
Kim CW; Kim J; Park Y; Cho DH; Lee JL; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
Cancer Res Treat; 2019 Jul; 51(3):1135-1143. PubMed ID: 30514068
[TBL] [Abstract][Full Text] [Related]
25. Lower survival after right-sided versus left-sided colon cancers: Is an extended lymphadenectomy the answer?
Lee L; Erkan A; Alhassan N; Kelly JJ; Nassif GJ; Albert MR; Rt Monson J
Surg Oncol; 2018 Sep; 27(3):449-455. PubMed ID: 30217301
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of primary tumour location after curative resection in Stage I-III colorectal cancer: a single-centre retrospective study.
Inoue M; Kanemitsu Y; Tsukamoto S; Moritani K; Takamizawa Y; Daiko H
Jpn J Clin Oncol; 2024 Mar; ():. PubMed ID: 38535894
[TBL] [Abstract][Full Text] [Related]
27. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of tumor location in stage IV colon cancer: a propensity score analysis in a multicenter study.
Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Hashiguchi Y; Sugihara K; Watanabe T
Int J Surg; 2014; 12(9):925-30. PubMed ID: 25091400
[TBL] [Abstract][Full Text] [Related]
29. The clinical value of C-reactive protein and its association with tumour location in patients undergoing curative surgery for colorectal cancer - a ScotScan collaborative study.
Fuglestad AJ; Meltzer S; Ree AH; McMillan DC; Park JH; Kersten C
Acta Oncol; 2022 Oct; 61(10):1248-1255. PubMed ID: 36068730
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcomes after resection of para-aortic lymph node metastasis from left-sided colon and rectal cancer.
Nakai N; Yamaguchi T; Kinugasa Y; Shiomi A; Kagawa H; Yamakawa Y; Numata M; Furutani A
Int J Colorectal Dis; 2017 Jul; 32(7):999-1007. PubMed ID: 28382511
[TBL] [Abstract][Full Text] [Related]
31. Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer.
Crozier JE; Leitch EF; McKee RF; Anderson JH; Horgan PG; McMillan DC
Am J Surg; 2009 Apr; 197(4):544-9. PubMed ID: 18614139
[TBL] [Abstract][Full Text] [Related]
32. Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?
Rossi S; Basso M; Strippoli A; Schinzari G; D'Argento E; Larocca M; Cassano A; Barone C
Clin Colorectal Cancer; 2017 Dec; 16(4):264-274. PubMed ID: 28412137
[TBL] [Abstract][Full Text] [Related]
33. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
34. The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
Park JH; Richards CH; McMillan DC; Horgan PG; Roxburgh CSD
Ann Oncol; 2014 Mar; 25(3):644-651. PubMed ID: 24458470
[TBL] [Abstract][Full Text] [Related]
35. Cancer invasion to Auerbach's plexus is an important prognostic factor in patients with pT3-pT4 colorectal cancer.
Fujita S; Nakanisi Y; Taniguchi H; Yamamoto S; Akasu T; Moriya Y; Shimoda T
Dis Colon Rectum; 2007 Nov; 50(11):1860-6. PubMed ID: 17899273
[TBL] [Abstract][Full Text] [Related]
36. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.
Dolan RD; Lim J; McSorley ST; Horgan PG; McMillan DC
Sci Rep; 2017 Dec; 7(1):16717. PubMed ID: 29196718
[TBL] [Abstract][Full Text] [Related]
37. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
[TBL] [Abstract][Full Text] [Related]
38. The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
van Wyk HC; Park JH; Edwards J; Horgan PG; McMillan DC; Going JJ
Br J Cancer; 2016 Jul; 115(2):156-63. PubMed ID: 27299960
[TBL] [Abstract][Full Text] [Related]
39. A combined analysis of mismatch repair status and thymidylate synthase expression in stage II and III colon cancer.
Öhrling K; Karlberg M; Edler D; Hallström M; Ragnhammar P
Clin Colorectal Cancer; 2013 Jun; 12(2):128-35. PubMed ID: 23276521
[TBL] [Abstract][Full Text] [Related]
40. Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70.
Lu CS; Chang PY; Chen YG; Chen JH; Wu YY; Ho CL
PLoS One; 2015; 10(9):e0138632. PubMed ID: 26382962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
